Find clinical trials for Non-Hodgkin Lymphoma in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Orlando, FL, USA:
and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...
Phase 1, Phase 2
Orlando, Florida, United States and 76 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Orlando, Florida, United States and 37 other locations
in participants with relapsed or refractory (R/R) aggressive B-cell Non-Hodgkin's lymphoma (DLBCL) who are using a combina...
Phase 2
Orlando, Florida, United States and 49 other locations
CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma...
Phase 3
Orlando, Florida, United States and 38 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Lake Mary, Florida, United States and 55 other locations
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in...
Phase 1, Phase 2
Lake Mary, Florida, United States and 11 other locations
20-expressing Non-Hodgkin lymphoma....
Phase 1
Orlando, Florida, United States and 12 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...
Phase 2
Lake Mary, Florida, United States and 71 other locations
doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects ≤75 years of age with previously untreated non-germinal....
Phase 3
Orlando, Florida, United States and 254 other locations
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...
Phase 3
Orlando, Florida, United States and 263 other locations
Clinical trials
Research sites
Resources
Legal